We are live on ! Find out more
MDXG icon

MiMedx Group

194 hedge funds and large institutions have $580M invested in MiMedx Group in 2024 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 60 increasing their positions, 63 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.57% more ownership

Funds ownership: 64.27%66.83% (+2.6%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

5% less repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 63

4% less funds holding

Funds holding: 202194 (-8)

12% less capital invested

Capital invested by funds: $657M → $580M (-$77.5M)

25% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 28

88% less call options, than puts

Call options by funds: $56K | Put options by funds: $484K

Holders
194
Holders Change
-8
Holders Change %
-3.96%
% of All Funds
2.79%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
21
Increased
60
Reduced
63
Closed
28
Calls
$56K
Puts
$484K
Net Calls
-$428K
Net Calls Change
-$13K
Name Holding Trade Value Shares
Change
Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
$2.88M -$1.01M -151,906 -24%
Prudential Financial
27
Prudential Financial
New Jersey
$2.75M -$816K -123,200 -21%
AW
28
Apricus Wealth
South Carolina
$2.67M
Citadel Advisors
29
Citadel Advisors
Florida
$2.64M +$2.69M +405,648 +1,006%
PCM
30
Prelude Capital Management
New York
$2.35M -$162K -24,487 -6%
DGI
31
Disciplined Growth Investors
Minnesota
$2.1M +$18.1K +2,737 +0.8%
Marshall Wace
32
Marshall Wace
United Kingdom
$2.06M +$329K +49,709 +17%
Wellington Management Group
33
Wellington Management Group
Massachusetts
$1.88M +$222K +33,461 +12%
N
34
Nuveen
North Carolina
$1.83M
IP
35
Isthmus Partners
Wisconsin
$1.81M -$575K -86,801 -22%
Jane Street
36
Jane Street
New York
$1.81M +$1.16M +174,797 +134%
Two Sigma Advisers
37
Two Sigma Advisers
New York
$1.76M -$1.56M -236,000 -44%
JP Morgan Chase
38
JP Morgan Chase
New York
$1.76M +$1.43M +215,995 +265%
Fisher Asset Management
39
Fisher Asset Management
Washington
$1.73M -$158K -23,849 -8%
UBS Group
40
UBS Group
Switzerland
$1.65M +$1.05M +159,200 +132%
Connor, Clark & Lunn Investment Management (CC&L)
41
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.61M -$223K -33,659 -11%
Barclays
42
Barclays
United Kingdom
$1.55M +$1.08M +163,005 +164%
Susquehanna International Group
43
Susquehanna International Group
Pennsylvania
$1.52M -$258K -38,990 -13%
Swiss National Bank
44
Swiss National Bank
Switzerland
$1.37M
GC
45
Globeflex Capital
California
$1.27M -$298K -44,910 -17%
UBS AM
46
UBS AM
Illinois
$1.16M -$220K -33,241 -14%
PCM
47
Parsons Capital Management
Rhode Island
$1.13M -$176K -26,500 -12%
Allspring Global Investments
48
Allspring Global Investments
North Carolina
$1.08M +$12.1K +1,822 +1%
TCWA
49
Turtle Creek Wealth Advisors
Texas
$1.07M
Wells Fargo
50
Wells Fargo
California
$1.07M -$33.6K -5,073 -3%

MDXG Hedge Fund Activity: Q3 2024 in Review

194 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in MiMedx Group (MDXG) for Q3 2024, worth a combined $580M — down 12% from $657M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of MDXG and 21 opened new positions — a net loss of 7 holders — while 63 trimmed existing stakes and 60 added.

The largest buyer was Trigran Investments, adding an estimated $21.3M. The largest seller was Arrowstreet Capital, cutting an estimated $5.57M.

  • 194 institutional investors held MiMedx Group (MDXG) as of Q3 2024, down from 202 in Q2 2024.
  • Funds reported $580M of MiMedx Group stock for Q3 2024, down 12% quarter-over-quarter.
  • 21 funds opened new MiMedx Group positions in Q3 2024 and 28 closed out, a net change of -7 holders.
  • The largest MiMedx Group buyer in Q3 2024 was Trigran Investments, an estimated $21.3M added.
  • The largest MiMedx Group seller in Q3 2024 was Arrowstreet Capital, an estimated $5.57M sold.

Based on aggregated 13F filings for Q3 2024.